Baird Financial Group
CRL icon

Baird Financial Group’s Charles River Laboratories CRL Stock Holding History

Baird Financial Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$323K Buy
1,875
+28
+2% +$5.19K ﹤0.01% 1614
2025
Q4 		$368K Sell
1,847
-22
-1% -$3.99K ﹤0.01% 1575
2025
Q3 		$292K Sell
1,869
-278
-13% -$44.2K ﹤0.01% 1648
2025
Q2 		$326K Sell
2,147
-421
-16% -$56.1K ﹤0.01% 1556
2025
Q1 		$387K Sell
2,568
-24
-0.9% -$4.02K ﹤0.01% 1468
2024
Q4 		$478K Sell
2,592
-5,494
-68% -$1.06M ﹤0.01% 1396
2024
Q3 		$1.59M Sell
8,086
-28
-0.3% -$5.82K ﹤0.01% 1030
2024
Q2 		$1.68M Buy
8,114
+2,594
+47% +$588K ﹤0.01% 1013
2024
Q1 		$1.5M Buy
5,520
+3,247
+143% +$775K ﹤0.01% 1035
2023
Q4 		$537K Buy
2,273
+197
+9% +$38.7K ﹤0.01% 1327
2023
Q3 		$407K Buy
+2,076
New +$426K ﹤0.01% 1405
2022
Q4 		– Sell
-150,586
Closed -$29.6M – 1697
2022
Q3 		$29.6M Sell
150,586
-17,313
-10% -$3.74M 0.09% 228
2022
Q2 		$35.9M Buy
167,899
+56,069
+50% +$13.7M 0.1% 217
2022
Q1 		$31.8M Buy
111,830
+110,954
+12,666% +$34.2M 0.08% 242
2021
Q4 		$330K Sell
876
-137
-14% -$53.2K ﹤0.01% 1634
2021
Q3 		$418K Buy
+1,013
New +$421K ﹤0.01% 1540

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baird Financial Group's CRL Position: Q1 2026 in Review

Baird Financial Group increased its Charles River Laboratories (CRL) stake by 1.5% in Q1 2026, buying an estimated $5.19K and bringing the position to 1,875 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #1614.

Baird Financial Group first reported a position in CRL in Q3 2021 and has held it in 16 quarters since. The position peaked at $35.9M in Q2 2022. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Baird Financial Group held 1,875 shares of Charles River Laboratories worth $323K as of Q1 2026.
  • Baird Financial Group bought 28 Charles River Laboratories shares in Q1 2026, an estimated $5.19K.
  • Charles River Laboratories made up ﹤0.01% of Baird Financial Group's portfolio in Q1 2026, its #1614 holding.
  • Baird Financial Group first reported a position in Charles River Laboratories in Q3 2021 and has held it in 16 quarters since.
  • Baird Financial Group's Charles River Laboratories position peaked at $35.9M in Q2 2022.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.